Trial Profile
A multicenter, observational, retrospective study of telavancin in patients with osteomyelitis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Feb 2020
Price :
$35
*
At a glance
- Drugs Telavancin (Primary)
- Indications Osteomyelitis
- Focus Therapeutic Use
- 28 Dec 2016 New trial record
- 30 Oct 2016 Results presented at the IDWeek 2016.